ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 919

B Cell Derived IFN-γ Contributes To The Negative Regulation Of T-Regulatory Cell Differentiation In Arthritis

Susan Olalekan1, Yanxia Cao2 and Alison Finnegan2, 1Immunology, Rush University Medical Center, Chicago, IL, 2Dept of Medicine, Rush University Medical Center, Chicago, IL

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, T-Regulatory Cells and mouse model

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cells in Human and Animal Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Depletion of B cells using a monoclonal antibody against CD20 expressed on mature B cells has proven efficacious in patients with rheumatoid arthritis (RA). We have previously shown in our mouse model of RA, proteoglycan induced arthritis (PGIA), that depletion of B cells leads to enhanced T regulatory cell (Tregs) numbers and activity essential in the suppression of arthritis. This increase in Treg numbers and function correlated with a decrease in CD4+ T cell IFN-γ production. In this study, we investigate the effects of B cells on the generation of Tregs and how IFN-γ contributes to this process.

Methods:

An anti-CD20 mAb was used to deplete B cells in FOXP3egfp reporter mice 5 days after immunization intraperitoneally (i.p.) with a recombinant protein for the G1 domain of the human proteoglycan in adjuvant. Mice were sacrificed 4 days after B cell depletion. Naïve and memory CD4+CD25– T cells based on CD62L expression were isolated from wild type (WT) and IFN-γ knockout (IFN-γ-/-) mice and cultured under Treg differentiating conditions in the presence of  proinflammatory cytokines IL-12 and IFN-γ. Flow cytometry was performed and Tregs were phenotyped as CD4+ Foxp3+ cells. ELISA was used to measure cytokine production. In the in vivo transfer model CD4+CD62L+Foxp3– T cell were sorted from transgenic animals and transferred into congenic animals that were later immunized and B cell depleted. Mixed bone marrow chimeras were created by transferring bone marrow cells from B cell deficient and IFN-γ-/- mice in a 1:1 ratio into irradiated recipients. These mice were later immunized i.p. with G1 in adjuvant 3 times at 3 week intervals. Paws were examined every other day for arthritis.

Results:

We show that in vitro IFN-γ suppresses the differentiation of CD4+CD25–CD62L+ T cells into Foxp3+ Tregs. CD4+CD25–CD62L– T cells were resistant to Treg differentiation and this resistance correlates with copious IFN-γ production. Through an in vivo transfer model of transgenic T cells into congenic mice, we find that CD4+CD62L+Foxp3– T cells are converted into Tregs more effectively in B cell depleted mice as compared to the control group. To determine if IFN-γ is responsible for the suppression of Treg generation, we setup an in vitro Treg differentiation assay using WT and IFN-γ-/- CD4+CD25–CD62L+ T cells in the presence of TGF-β and WT or IFN-γ-/- B cells. We find that IFN-γ-/-B cells resulted in an increase in Treg differentiation in comparison to WT B cells. Chimeras with a specific deficiency in IFN-γ in B cells also show an increase in the percentage of Tregs.

Conclusion:

Our findings demonstrate that B cell derived IFN-γ can negatively regulate the generation of Tregs in arthritis.


Disclosure:

S. Olalekan,
None;

Y. Cao,
None;

A. Finnegan,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-derived-ifn-%ce%b3-contributes-to-the-negative-regulation-of-t-regulatory-cell-differentiation-in-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology